Our business model is based solely on the sales, marketing and distribution of branded pharmaceutical products in Greece and Cyprus, through exclusive partnership agreements with global biopharmaceutical companies.
Our existing partners are among the leaders of the global biopharmaceutical industry. Our distribution agreements give us exclusive product sales, marketing and distribution rights within Greece, Cyprus and, for certain products, other countries in Southeast Europe.
Our partners are responsible for the clinical development and manufacture of our products and all aspects of the regulatory approval process for such products, including obtaining relevant marketing authorizations. In connection with our sales and marketing activity, we provide local regulatory guidance, pharmacovigilance, logistics and storage services.